Back to search

Article

Cost Profiling of Tyrosine Kinase Inhibitors for Chronic Myeloid Leukemia Treatment in South Africa: Medicines That Are Still Too Expensive to Swallow

2021-08-06

Abstract excerpt

<h4>Background: </h4> The development of tyrosine kinase inhibitors (TKIs) has improved chronic myeloid leukemia (CML) management and increased CML prevalence due to low mortality rates. CML management is potentially lifelong and expensive and requires pharmacoeconomic approaches and regular review of therapy to ensure that patients obtain cost-effective therapeutic outcomes. Although the introduction of TKIs gene...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
0b79264c-29b6-5bed-9fb9-b85efbcc1f28
DOI
10.21203/rs.3.rs-751789/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Cost Profiling of Tyrosine Kinase Inhibitors for Chronic Myeloid Leukemia Treatment in South Africa: Medicines That Are Still Too Expensive to SwallowDOI 10.21203/rs.3.rs-751789/v1
Select a neighboring publication to make it the new centre.